...
首页> 外文期刊>The biochemical journal >Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate
【24h】

Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate

机译:响应于过氧化物酶促增殖剂的CiProfibrate,Wy-14,643和二 - (2-乙基己基)邻苯二甲酸酯的蛋白质组成的特异性变化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

pThe hypolipidaemic agents ciprofibrate and Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid) and the phthalate-ester plasticizer di-(2-ethylhexyl)-phthalate (DEHP), like other peroxisome proliferators, produce a significant hepatomegaly and induce the peroxisomal fatty acid beta-oxidation enzyme system together with profound proliferation of peroxisomes in hepatic parenchymal cells. Changes in the profile of liver proteins in rats following induction of peroxisome proliferation by ciprofibrate, Wy-14,643 and DEHP have been analysed by high-resolution two-dimensional gel electrophoresis. The proteins of whole liver homogenates from normal and peroxisome-proliferator-treated rats were separated by two-dimensional gel electrophoresis using isoelectric focusing for acidic proteins and nonequilibrium pH gradient electrophoresis for basic proteins. In the whole liver homogenates, the quantities of six proteins in acidic gels and six proteins in the basic gels increased following induction of peroxisome proliferation. Peroxisome proliferator administration caused a repression of three acidic proteins in the liver homogenates. By the immunoblot method using polyspecific antiserum against soluble peroxisomal proteins and monospecific antiserum against peroxisome proliferation associated Mr 80000 polypeptide (polypeptide PPA-80), the majority of basic proteins induced by these peroxisome proliferators appeared to be peroxisomal proteins. Polypeptide PPA-80 becomes the most abundant protein in the total liver homogenates of peroxisome-proliferator-treated rats. These results indicate that ciprofibrate, DEHP and Wy-14,643 induce marked changes in the profile of specific hepatic proteins and that some of these changes should serve as a baseline to identify a set of gene products that may assist in defining the specific ‘peroxisome proliferator domain’./p
机译:>高磷脂剂Ciprofiblate和Wy-14,643([4-氯-6-(2,3- Xylidino)-2-嘧啶硫氨基乙基乙酸)和邻苯二甲酸酯增塑剂二(2-乙基己基) - 苯二甲酸酯(如其他过氧化物酶促增殖剂,如其他过氧化物体增殖剂,产生了显着的肝脏肝脏,并诱导过氧血清脂肪酸β-氧化酶系统以及肝实质细胞中的过氧化物的深度增殖。通过高分辨率二维凝胶电泳分析了通过高分辨率二维凝胶电泳分析了通过高分辨率二维凝胶电泳进行过氧化物酶体增殖后大鼠肝蛋白质概况的变化。通过使用等电聚焦用于酸性蛋白质的等电聚焦,通过二维凝胶电泳分离来自正常和过氧化物体增殖物处理的大鼠的全肝脏匀浆的蛋白质,用于酸性蛋白质,对碱性蛋白质非均匀的pH梯度电泳。在整个肝脏匀浆中,在诱导过氧化物增殖后,酸性凝胶中的六种蛋白质和六种蛋白质的量增加。过氧化物体增殖剂给药在肝脏匀浆中抑制了三种酸性蛋白质。通过免疫印刷方法对来自溶性过氧血清蛋白质和单特异性抗血清过氧化物体增殖的单特异性抗血清的免疫印迹方法相关MR 80000多肽(多肽PPA-80),这些过氧缺血剂增殖剂诱导的大多数碱性蛋白质似乎是过氧血清蛋白质。多肽PPA-80成为过氧化物体 - 增殖物处理的大鼠总肝脏匀浆中最丰富的蛋白质。这些结果表明,CiProfibrate,DeHP和Wy-14,643诱导特定肝蛋白质谱的显着变化,并且一些这些变化应该用作鉴定一组可以有助于定义特定的“过氧化物体增殖域结构域的基因产物的基线'。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号